Molecular characteristics of NPM1 mutations in AML patients using targeted NGS
Background Acute myeloid leukemia (AML) is a clonal hematopoietic stem cell malignancy characterized by the accumulation of myeloid progenitor cells with arrested differentiation, leading to the suppression of normal hematopoiesis. The disease exhibits significant heterogeneity, with less than 30% f...
Saved in:
Main Authors: | Reham AboElwafa, Magdy Elbordiny, Ashraf Elghandour, Rania Swelem, Sherouk Shoeib |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Alexandria Journal of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/20905068.2024.2395583 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KRAS mutations in patients with AML: clinical characteristics and not reported mutations using NGS
by: Salma Said Ibrahim Elsayed, et al.
Published: (2024-12-01) -
Molecular profiling of acute myeloid leukemia with Runx1-Runx1t1 fusion
by: Magdy Elbordiny, et al.
Published: (2024-12-01) -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE
by: Gianfranco Catalano, et al.
Published: (2020-10-01) -
The Clinical Impact of NPM1 Mutations and the Effect of Concurrent Mutations in Acute Myeloid Leukemia: Unraveling the Prognostic Significance
by: Faten Moassass, et al.
Published: (2024-12-01) -
A distinct subgroup of AML resembling the APL immunophenotype is associated with DIC
by: Pan Li, et al.
Published: (2024-12-01)